Cirbloc M Hyo RSSAuthorisedThis medicine is authorised for use in the European Unionmycoplasma hyopneumoniae, strain 2940, inactivated / porcine circovirus 2, ORF2 capsid proteinMedicineVeterinaryAuthorised
Page contents OverviewProduct detailsAuthorisation detailsAssessment historyNews on Cirbloc M HyoApplication under evaluationCVMP opinionEuropean Commission decisionOverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information websiteProduct details Name of medicine Cirbloc M Hyo Active substance mycoplasma hyopneumoniae, strain 2940, inactivatedporcine circovirus 2, ORF2 capsid protein International non-proprietary name (INN) or common name mycoplasma hyopneumoniae, strain 2940, inactivatedporcine circovirus 2, ORF2 capsid proteinPharmacotherapeutic groupImmunologicals for suidaeInactivated viral and inactivated bacterial vaccinesAuthorisation details EMA product number EMEA/V/C/006131 Assessment historyInitial marketing authorisation documentsCVMP summary of positive opinion for Cirbloc M HyoAdoptedReference Number: EMA/CVMP/413939/2024 English (EN) (147.37 KB - PDF)First published: 13/09/2024ViewNews on Cirbloc M HyoMeeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 September 202413/09/2024This page was last updated on 05/11/2024Share this page